SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced that it has entered into a US co-distribution agreement for its CanGaroo® Bio Envelope with BIOTRONIK, Inc., a global leader in cardio- and endovascular medical technology. CanGaroo Bio Envelopes are a natural extracellular matrix (ECM) scaffold that […]
Other News
Teleflex Announces First Quarter 2018 Earnings Conference Call Information
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2018 will be released before market open on Thursday, May 3, 2018. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, May 3, 2018. The call can be accessed through a […]
Ra Medical Systems Appoints Andrew Jackson as Chief Financial Officer
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, manufacturers of laser-based solutions for the treatment of cardiovascular and dermatological diseases, announced today that the Company has appointed Andrew Jackson as its Chief Financial Officer, effective immediately. Mr. Jackson has over 20 years of finance experience in life science and technology companies, including extensive […]
APN Health Announces Commercial Release of its Innovative Cardiac Mapping System
MILWAUKEE–(BUSINESS WIRE)–APN Health, LLC (www.apnhealth.com) announces its Navik 3D mapping system is commercially released and in clinical use. The first clinical case using the technology was performed on March 22nd at St. Luke’s Medical center in Milwaukee. Navik 3D is intended for catheter-based atrial and ventricular mapping using compatible catheters […]
Penumbra, Inc. Schedules First Quarter 2018 Earnings Release and Conference Call for May 8, 2018
ALAMEDA, Calif., April 18, 2018 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2018 after market close on Tuesday, May 8, 2018 at 4:30 PM Eastern Time. A press release with first quarter 2018 financial results will be issued after market […]
HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair
ZWICKAU, Germany, April 18, 2018 /PRNewswire/ — HeartStitch® has received its CE Mark in the European Union for its device for treatment of mitral valve repair. This approval will provide physicians the ability to remodel the leaflets of the mitral valve and reestablish proper coaptation. The CoAp Pro expands HeartStitch’s product line of cardiovascular […]
Emboline, Inc. Completes Funding Of Over $10 Million
SANTA CRUZ, Calif., April 19, 2018 /PRNewswire/ — Emboline, Inc., an emerging medical device company with a game-changing device for total embolic protection during transcatheter aortic valve replacement (TAVR) procedures, announced today that it has completed a Series B funding round totaling over $10 million. The funding includes $3 million in new […]
Bardy Diagnostics™ Recognized by MedTech Outlook as One of the Top 10 Cardio Vascular Device Companies of 2018
SEATTLE, April 19, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it has been recognized as one of the Top 10 Cardio Vascular Device Companies of 2018 by MedTech Outlook Magazine, an industry periodical committed to covering the […]
CryoLife Announces Release Date and Teleconference Call Details for 2018 First Quarter Financial Results
ATLANTA, April 17, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 first quarter financial results will be released on Wednesday, May 2, 2018 after the market closes. On Thursday, May 3, 2018 the Company will hold a teleconference call and live webcast at 8:00 […]
Abbott Reports First-Quarter 2018 Results
ABBOTT PARK, Ill., April 18, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2018. First-quarter worldwide sales of $7.4 billion increased 16.7 percent on a reported basis and 6.9 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.23 in the first quarter. Adjusted diluted EPS from […]



